Results 131 to 140 of about 40,918 (232)

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Advanced Materials, Volume 38, Issue 51, 11 September 2026.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo   +3 more
wiley   +1 more source

Programming Intrinsic States of Solvent-Free Glycolipids through Molecular Architecture and Thermal History. [PDF]

ACS Omega
Kim W, Hogan DE, Maier RM, Kim M.
europepmc   +1 more source

Kelvin Probe Force Microscopy in Bionanotechnology: Current Advances and Future Perspectives

Advanced Materials, Volume 38, Issue 51, 11 September 2026.
Kelvin probe force microscopy (KPFM) enables the nanoscale mapping of electrostatic surface potentials. While widely applied in materials science, its use in biological systems remains emerging. This review presents recent advances in KPFM applied to biological samples and provides a critical perspective on current limitations and future directions for
Ehsan Rahimi, Mario Palacios‐Corella, Arjan Mol, Salvador Pané, Josep Puigmartí‐Luis   +4 more
wiley   +1 more source

Structure-dependent interfacial behavior of bioinspired glycolipid surfactants. [PDF]

RSC Adv
Durkin TJ, Graves KR, Savagatrup S, Maier RM, Hogan DE.   +4 more
europepmc   +1 more source

Mechanistic Understanding of Protein–MOF Integration Through Surfactant‐Driven Interfacial Design

Advanced Science, Volume 13, Issue 52, 18 September 2026.
This study reveals how surfactant‐driven interfacial design governs the assembly and stability of protein@MOF composites. Using lipid‐based nonionic surfactants, we modulate protein–MOF interactions to improve encapsulation efficiency, MOF crystallization, and catalytic performance.
Ehsan Rashidniyaghi, Mohammad Khavani, Carlie Coerver, Ruibin Liang, Raheleh Ravanfar   +4 more
wiley   +1 more source

Exploring glycocalyx components powering the contact between Entamoeba histolytica and bacteria during non-opsonic phagocytosis. [PDF]

PLoS Pathog
Labruyère E, Treport T, Olivo-Marin JC, Guillen N.   +3 more
europepmc   +1 more source

Solid-Phase Glycolipid Synthesis Expedites Liposome Functionalization. [PDF]

J Am Chem Soc
Sigler M, Hon C, Pohl KG, Sander LE, Ricardo MG, Seeberger PH.   +5 more
europepmc   +1 more source

Exploring the Multitarget Pharmacological Potential of Halogeton sativus Secondary Metabolites: An Integrated Experimental and Computational Approach

Chemistry &Biodiversity, Volume 23, Issue 9, September 2026.
Halogeton sativus is investigated through phytochemical isolation, biological evaluation, molecular dicking, molecular dynamics simulation, and ADMET prediction. The identified metabolites exhibit promising antioxidant, anti‐inflammatory, antimicrobial, and antidiabetic activities, while computational analyses provide mechanistic insights and favorable
Abd Elbasset Tamersit, Soumia Mouffouk, Chaima Mouffouk, Faizul Azam, Rayan A. Mulla, Najeh Kharbatia, Mariusz Jaremko, Abdul‐Hamid Emwas, Nourhene Hamdaoui, Saoudi Mongi, Sara Mouffouk, Waffa Bouafia, Hamada Haba   +12 more
wiley   +1 more source

Distinct Lipid Compositions in Seawater and the Sea Surface Microlayer Measured with Liquid Chromatography and High-Resolution Mass Spectrometry. [PDF]

ACS Earth Space Chem
Birt AE, Ammer D, Agblemanyo FE, Wozniak AS, Frossard AA.   +4 more
europepmc   +1 more source

Natural Lactone‐Based Quorum Sensing Inhibitors Attenuate Virulence in Pseudomonas aeruginosa

Chemistry &Biodiversity, Volume 23, Issue 9, September 2026.
Targeting bacterial communication, lab‐generated lactones (Lx) inhibited biofilm formation and eliminated mature biofilms within 24–48 h. Lx treatment also suppressed pyocyanin and rhamnolipid production while downregulating rhlR expression, highlighting their promise as potent quorum‐sensing (QS) inhibitors and next‐generation antibiofilm therapeutics.
Shivani Chaturvedi, Ashutosh Sharma, Tanisha Singh, Bibhuti Bhusan Das, Tanmay Dutta, Sunil Kumar Khare   +5 more
wiley   +1 more source